Amyotrophic Lateral Sclerosis Treatment Market Size, Share & Trends Report

Amyotrophic Lateral Sclerosis Treatment Market Size, Share & Trends Analysis Report By Treatment (Medication, Stem Cell Therapy), By Type (Sporadic), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68038-001-9
Number of Report Pages: 100
Format: PDF

Historical Range: 2018 - 2022
Forecast Period: 2024 - 2030
Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
  1.2. Market Definitions
  1.3. Research Methodology
1.3.1. Information Procurement
  1.3.2. Information or Data Analysis
  1.3.3. Market Formulation & Data Visualization
  1.3.4. Data Validation & Publishing
  1.4. Research Scope and Assumptions
  1.4.1. List of Data Sources
Chapter 2. Executive Summary
  2.1. Market Outlook
  2.2. Segment Outlook
  2.3. Competitive Insights
Chapter 3. Amyotrophic Lateral Sclerosis Treatment Market Variables, Trends, & Scope
  3.1. Market Introduction/Lineage Outlook
  3.2. Market Size and Growth Prospects (USD Million)
  3.3. Market Dynamics
  3.3.1. Market Drivers Analysis
  3.3.2. Market Restraints Analysis
  3.4. Amyotrophic Lateral Sclerosis Treatment Market Analysis Tools
  3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
  3.4.1.2. Bargaining power of the buyers
  3.4.1.3. Threats of substitution
  3.4.1.4. Threats from new entrants
  3.4.1.5. Competitive rivalry
  3.4.2. PESTEL Analysis
  3.4.2.1. Political landscape
  3.4.2.2. Economic and Social landscape
  3.4.2.3. Technological landscape
  3.4.2.4. Environmental landscape
  3.4.2.5. Legal landscape
Chapter 4. Amyotrophic Lateral Sclerosis Treatment Market: Treatment Estimates & Trend Analysis
  4.1. Segment Dashboard
  4.2. Amyotrophic Lateral Sclerosis Treatment Market: Treatment Movement Analysis, 2023 & 2030 (USD Million)
  4.3. Medication
  4.3.1. Medication Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.3.2. Riluzole
  4.3.2.1. Riluzole Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.3.3. Edaravone
  4.3.3.1. Edaravone Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.3.4. Others
  4.3.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.4. Stem Cell Therapy
  4.4.1. Stem Cell Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.5. Others
  4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Amyotrophic Lateral Sclerosis Treatment Market: Type Estimates & Trend Analysis
  5.1. Segment Dashboard
  5.2. Amyotrophic Lateral Sclerosis Treatment Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  5.3. Sporadic ALS
  5.3.1. Sporadic ALS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.4. Familial ALS
  5.4.1. Familial ALS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Amyotrophic Lateral Sclerosis Treatment Market: Distribution Channel Estimates & Trend Analysis
  6.1. Segment Dashboard
  6.2. Amyotrophic Lateral Sclerosis Treatment Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
  6.3. Hospital Pharmacies
  6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4. Retail Pharmacies
  6.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.5. Others
  6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Amyotrophic Lateral Sclerosis Treatment Market: Regional Estimates & Trend Analysis
  7.1. Amyotrophic Lateral Sclerosis Treatment Market Share, By Region, 2023 & 2030 (USD Million)
  7.2. North America
  7.2.1. North America Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.2. U.S.
  7.2.2.1. U.S. Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.3. Canada
  7.2.3.1. Canada Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.4. Mexico
  7.2.4.1. Mexico Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3. Europe
  7.3.1. Europe Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.2. UK
  7.3.2.1. UK Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.3. Germany
  7.3.3.1. Germany Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.4. France
  7.3.4.1. France Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.5. Italy
  7.3.5.1. Italy Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.6. Spain
  7.3.6.1. Spain Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.7. Denmark
  7.3.7.1. Denmark Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.8. Sweden
  7.3.8.1. Sweden Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.9. Norway
  7.3.9.1. Norway Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4. Asia Pacific
  7.4.1. Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.2. China
  7.4.2.1. China Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.3. Japan
  7.4.3.1. Japan Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.4. India
  7.4.4.1. India Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.5. Australia
  7.4.5.1. Australia Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.6. South Korea
  7.4.6.1. South Korea Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.7. Thailand
  7.4.7.1. Thailand Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.5. Latin America
  7.5.1. Latin America Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.5.2. Brazil
  7.5.2.1. Brazil Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.5.3. Argentina
  7.5.3.1. Argentina Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6. Middle East and Africa
  7.6.1. Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.2. South Africa
  7.6.2.1. South Africa Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.3. Saudi Arabia
  7.6.3.1. Saudi Arabia Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.4. UAE
  7.6.4.1. UAE Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.5. Kuwait
  7.6.5.1. Kuwait Amyotrophic Lateral Sclerosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
  8.1. Recent Developments & Impact Analysis by Key Market Participants
  8.2. Company Categorization
  8.3. Company Heat Map Analysis
  8.4. Company Profiles
  8.4.1. Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Group Corporation)
  8.4.1.1. Participant’s Overview
  8.4.1.2. Financial Performance
  8.4.1.3. Product Benchmarking
  8.4.1.4. Recent Developments/Strategic Initiatives
  8.4.2. Biogen
  8.4.2.1. Participant’s Overview
  8.4.2.2. Financial Performance
  8.4.2.3. Product Benchmarking
  8.4.2.4. Recent Developments/Strategic Initiatives
  8.4.3. BrainStorm Cell Limited
  8.4.3.1. Participant’s Overview
  8.4.3.2. Financial Performance
  8.4.3.3. Product Benchmarking
  8.4.3.4. Recent Developments/Strategic Initiatives
  8.4.4. Amylyx Pharmaceuticals, Inc.
  8.4.4.1. Participant’s Overview
  8.4.4.2. Financial Performance
  8.4.4.3. Product Benchmarking
  8.4.4.4. Recent Developments/Strategic Initiatives
  8.4.5. Ionis Pharmaceuticals, Inc.
  8.4.5.1. Participant’s Overview
  8.4.5.2. Financial Performance
  8.4.5.3. Product Benchmarking
  8.4.5.4. Recent Developments/Strategic Initiatives
  8.4.6. Sanofi
  8.4.6.1. Participant’s Overview
  8.4.6.2. Financial Performance
  8.4.6.3. Product Benchmarking
  8.4.6.4. Recent Developments/Strategic Initiatives
  8.4.7. Otsuka Pharmaceutical Co., Ltd.
  8.4.7.1. Participant’s Overview
  8.4.7.2. Financial Performance
  8.4.7.3. Product Benchmarking
  8.4.7.4. Recent Developments/Strategic Initiatives
  8.4.8. F. Hoffmann-La Roche Ltd
  8.4.8.1. Participant’s Overview
  8.4.8.2. Financial Performance
  8.4.8.3. Product Benchmarking
  8.4.8.4. Recent Developments/Strategic Initiatives
  8.4.9. AB Science
  8.4.9.1. Participant’s Overview
  8.4.9.2. Financial Performance
  8.4.9.3. Product Benchmarking
  8.4.9.4. Recent Developments/Strategic Initiatives
  8.4.10. Sun Pharmaceutical Industries Ltd.
  8.4.10.1. Participant’s Overview
  8.4.10.2. Financial Performance
  8.4.10.3. Product Benchmarking
  8.4.10.4. Recent Developments/Strategic Initiatives
  8.4.11. Orion Corporation
  8.4.11.1. Participant’s Overview
  8.4.11.2. Financial Performance
  8.4.11.3. Product Benchmarking
  8.4.11.4. Recent Developments/Strategic Initiatives
  8.4.12. CORESTEMCHEMON Inc.
  8.4.12.1. Participant’s Overview
  8.4.12.2. Financial Performance
  8.4.12.3. Product Benchmarking
  8.4.12.4. Recent Developments/Strategic Initiatives

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.